Skip to main content

Table 3 Estimated mean change (±SE) from MMRMs for baseline to week 16, and baseline to week 20, for the three groups on clinical measures

From: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  1. Note: YMRS, Young Mania Rating Scale; CGI-BP Clinical Global Impressions Scale - Bipolar; BDRS, Bipolar Depression Rating Scale; MADRS, Montgomery-Asberg Depression Rating Scale; Brief Psychiatric Rating Scale, BPRS; GAF, Global Assessment of Functioning ; SOFAS, Social and Occupational Assessment Scale; QLS, Quality of Life Scale
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us